ALLMedicine™ Vitiligo Center

Mar 4th, 2021 - Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.|2021|Cotter C,Kretz M,Rajan N,|

Mar 3rd, 2021 - Topical tacrolimus is increasingly used nowadays in the treatment of vitiligo. We evaluated therapeutic outcomes of tacrolimus 0.03% in non-segmental vitiligo (NSV). Sixty-three patients with NSV were divided into groups A & B. Group A received 0....

Mar 2nd, 2021 - Melanocyte-specific CD8+ T cells enrichment correlates with the severity of vitiligo, and the role of A20 derived from myeloid cells in the enrichment of pathogenic T cells is unknown. Premelanosome (PMEL)-specific transgenic CD8+ T cells were ado...

Mar 1st, 2021 - Human beta defensin- 1(hBD-1); an antimicrobial peptide, has immune regulatory effects which may be involved in autoimmunity. The aims were to evaluate the association between defensin beta 1 (DEFB1) (-44 C/G) and (-20 G/A) gene polymorphisms with...

Feb 27th, 2021 - Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk depositi...

Feb 27th, 2013 - Vitiligo is an acquired pigment disorder in which depigmented macules result from the loss of melanocytes from the involved regions of skin and hair. The color dissimilarity on the cosmetically sensitive regions frequently induces quality of life ...

Aug 6th, 2012 - The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. T...

Nov 27th, 2008 - This detailed and user-friendly guideline for the diagnosis and management of vitiligo in children and adults aims to give high quality clinical advice, based on the best available evidence and expert consensus, taking into account patient choice ...

Mar 4th, 2021 - Regulatory noncoding RNAs help protect keratinocytes from ultraviolet-mediated damage in vitiligo.|2021|Cotter C,Kretz M,Rajan N,|

Mar 3rd, 2021 - Topical tacrolimus is increasingly used nowadays in the treatment of vitiligo. We evaluated therapeutic outcomes of tacrolimus 0.03% in non-segmental vitiligo (NSV). Sixty-three patients with NSV were divided into groups A & B. Group A received 0....

Mar 2nd, 2021 - Melanocyte-specific CD8+ T cells enrichment correlates with the severity of vitiligo, and the role of A20 derived from myeloid cells in the enrichment of pathogenic T cells is unknown. Premelanosome (PMEL)-specific transgenic CD8+ T cells were ado...

Mar 1st, 2021 - Human beta defensin- 1(hBD-1); an antimicrobial peptide, has immune regulatory effects which may be involved in autoimmunity. The aims were to evaluate the association between defensin beta 1 (DEFB1) (-44 C/G) and (-20 G/A) gene polymorphisms with...

Feb 27th, 2021 - Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk depositi...

Oct 8th, 2020 - Takeaway Combination treatment with hand-held narrowband-ultraviolet B (NB-UVB) light and potent topical corticosteroid (TCS) is likely to result in improved treatment response in patients with localised non-segmental vitiligo compared with potent...

Sep 20th, 2020 - NEW YORK (Reuters Health) - Vitiligo patients who receive long-term narrowband UVB phototherapy are at lower risk of major osteoporotic fractures, new research shows. "Systemic phototherapy to treat vitiligo can unexpectedly reduce the risk of fra...

Mar 19th, 2020 - Spillover to other diseases JAK inhibitors – some in oral and some in topical form – are showing efficacy in ongoing research for alopecia areata (AA) and vitiligo as well, Dr. Blauvelt said.

Feb 19th, 2020 - LAHAINA, HAWAII – Individuals with vitiligo demonstrated a markedly reduced rate of internal malignancies in a recent first-of-its-kind “big data” study from South Korea, Iltefat Hamzavi, MD, said at the Hawaii Dermatology Seminar provided by Glob.

Feb 5th, 2020 - To the Editor: Pembrolizumab is an anti–programmed death receptor 1 humanized monoclonal antibody used for treating advanced or metastatic melanoma. 1 It is associated with several immune-related adverse events because it blocks a T-cell receptor c.